Crohn’s Disease
Crohn’s disease is a type of inflammatory bowel disease (IBD) that causes inflammation of the digestive tract, leading to symptoms like abdominal pain, diarrhea, and weight loss.
New Imaging Tracer for Liver and GI Diseases
We are investigating a special imaging agent in healthy people and patients with liver and gastrointestinal conditions. This study aims to see how effectively it binds to specific receptors related to these diseases.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Primary Sclerosing Cholangitis
Primary sclerosing cholangitis is a chronic liver disease that damages the bile ducts, leading to liver damage and symptoms such as jaundice and itching.
Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease is a condition characterized by the accumulation of fat in the liver, which can lead to inflammation and liver damage.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CTC Clinical Trial Consultants AB
CTC
Bergshamra, Sweden
CTC Clinical Trial Consultants AB
CTC
Uppsala, Sweden
Uppsala University Hospital
Section of Gastroenterology/Hepatology
Uppsala, Sweden
Sponsor: Antaros Medical AB
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.